The role of the retinoblastoma gene (RBI) in human gastric carcinogenesis is yet to be clarified. We report on the analysis of RB1 structure and protein (pRB) expression in gastric carcinomas using Southern blotting, Western blotting and immunohistochemistry. The relationship between pRB expression and cell proliferation was assessed by a proliferation marker (PCNA) in a subset of cases. Non-neoplastic mucosas were studied, as controls, by the same methodology. We found a close relationship between pRB expression and PCNA in non-neoplastic mucosas as well as in gastric carcinomas. All tumours were immunohistochemically positive for pRB, although with a variable proportion of non-immunoreactive cells. Carcinomas of the diffuse type showed absence of pRB expression in a larger proportion of neoplastic cells than carcinomas of the intestinal type (P<0.05). Analysis of the RBI structure using probe p68RS2.0 revealed allelic imbalance in 29% of informative cases. No homozygous deletions and/or rearrangements were detected with p68RS2.0 and cDNA probes. Western analysis revealed no abnormal patterns of pRB. Our data therefore suggest that major alterations affecting the RB1 gene are rather infrequent in human gastric carcinomas.
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During the last decade there has been an increasing interest in studying gene molecular alterations that may be related to neoplastic initiation. One of the best-studied examples of such cause-effect molecular mechanisms is the mutational inactivation of the retinoblastoma gene (RBI), an oncosuppressor gene mapped to 13ql4.2. RBI inactivation leads to the development of retinoblastoma, a rare eye tumour of proliferating retina. For retinoblastoma development, inactivating 'hits' on both RBI alleles must occur in a precursor cell of the retina (Knudson, 1971; Cavenee et al., 1983; Dryja et al., 1986; Friend et al., 1986; Fung et al., 1987 ; Lee et al., 1987) .
Mutational inactivation of RBI occurs frequently in osteosarcomas (Toguchida et al., 1988; Shew et al., 1989 ) and soft-tissue sarcomas (Friend et al., 1987; Reissman et al., 1989) , which suggests that RBI plays an important role in the development of these tumours. RBI inactivation has been observed in other malignant tumours, namely cancers of the breast (Lee et al., 1988; Varley et al., 1989) , bladder (Horowitz et al., 1989; Ishikawa et al., 1991; Cairns et al., 1991) , prostate (Bookstein et al., 1990) and lung (Harbour et al., 1988; Yokota et al., 1988; Hensel et al., 1990) , as well as in several types of leukaemia (Furukawa et al., 1991) . It is -unlikely that RBI inactivation is a crucial step in the development of these tumours as only a proportion of them have RBI abnormalities.
To our knowledge, gastric cancer has not yet been evaluated for RBI alterations, although loss of heterozygosity for chromosome 13 had been reported in some gastric carcinomas (Motomura et al., 1988; Wada et al., 1988) .
We report on the analysis, using immunohistochemistry, Detailed clinical and histopathological data of all patients and tumours were available (Table I) .
The relationship between pRB immunoreactivity and a cell proliferation marker in gastric carcinomas and corresponding normal mucosas, as determined by PCNA immunoreactivity in serial frozen sections, was studied in a subset of cases.
Flow cytometry data (e.g. DNA ploidy, DNA index, proliferative index and S-phase fraction) from some cases of the present series were already available (David et al., 1994) and used to correlate pRB expression to proliferation.
Immunohistochemistry, Several serial cryostat sections (6pm) were obtained from each sample, stored at -70°C, and used for immunoreactivity studies with pRB and PCNA monoclonal antibodies.
RB protein Gastric carcinomas and matched mucosas were analysed with two monoclonal antibodies (PMG3-245 and NCL-RB) with recognised affinity for the RB1 gene product (De Caprio et al., 1988; Birtek et al., 1992) .
Frozen sections from a poorly differentiated sporadic retinoblastoma, obtained from the left eye of a 3-year-old boy, were used as negative biological controls:
1 Western analvsis Total protein was extracted from 12 primary gastric carcinomas and two normal mucosas (distant from the tumours). Briefly, fresh tissue was sonicated in ice-cold sample buffer (Tris 0.5 M pH 6.8, 2% SDS, 10% glycerol and 5% mercaptoethanol). Proteins were separated by 6% SDS-PAGE and electroblotted to nitrocellulose (Schleicher & Schuell) membranes. Membranes were incubated with NCL-RB antibody at the final concentration of 2.5 gg mlfor 120 min. Colour development was performed using a streptavidin, biotin, alkaline phosphatase system (RPN22, Amersham) in accordance with the manufacturer's recommendations.
Total protein extracted from a retinoblastoma-derived cell line (WERI-RB-1) and from a neuroblastoma cell line (IMR-32) was used as a negative and positive control respectively ( Figure 1 ).
Southern analysis High molecular weight DNA was extracted according to standard procedures (Mullenbach et al., 1989) (Wiggs et al., 1988) . Probe pI23Ml.8 is located upstream of exon 1 (Blanquet et al., 1991) and was used to detect exons 1 and 2 in DNA samples digested with Sacl. cDNA probes pGH2 0.6 and pG3.8M cover exons 3-8 and exons 9-27 respectively (Fung et al., 1987) .
DNA samples with altered patterns for probe p68RS2.0 were further screened with probe p123Ml.8 detecting a BanHI polymorphism.
The 1.2 kb BglII/Hind -3'BCR (22q1 1) probe provided a reference for equal loading of DNA.
The probes were labelled by primer extension (Feinberg et al., 1983) . Autoradiograms were examined after 2-7 days' exposure at -70'C.
All bands from the autoradiograms were scored visually against the control probe. Dosimetric analysis of the intensity of the hybridisation signals, in cases where changes were visually detected, was accomplished by automated scanning densitometry (LKB Gelscan XL).
Statistical antalysis
Kappa statistics was performed as a measure of interobserver agreement. Kappa (K) values above 0.75 reflect excellent agreement and scores between 0.60 and 0.75 reflect good agreement (Landis et al., 1977) . RBI (Figure 2 ). The majority (88%) scored as + + (51-100% stained cells) ( Table H) .
The percentage of intestinal carcinomas displaying high (+ +) pRB immunoreactivity (100%) was significantly higher (P<0.05) than that of diffuse carcinomas (70%) ( Table III) and non-significantly higher than that of atypical carcinomas (80%). No other significant associations were found between loss of pRB immunoreactivity and the clinicopathological features presented in Table I (Figure 1) , except for patients 28 (Figure 1 ) and 33, in whom no phosphorylated forms of pRB were detected using this method. (Table IV) . In the remaining cases no differences in intensity of the cDNA RBI hybridisation signals of tumour and normal mucosas were detected when compared with chromosome 22 control probe.
Results with probe pl23M1.8/BanHl revealed that the alterations detected in three cases (patients 28, 30 and 36) started within the RBI gene (Table IV) . Table IV summarises the Southern analysis results of the cases with alterations affecting RBI.
All patients showing alterations within the RBI gene had advanced-stage tumours (Table IV) .
All tumours with allelic imbalance for the RBI locus were immunohistochemically scored as + + (51-100% immunoreactive cells), with the exception of tumours from patient 36 (scored as +: 10-50% immunoreactive cells) (Table IV) .
We found a close relationship between pRB immunoreactivity and cell proliferation (PCNA) in non-neoplastic gastric mucosas. Accordingly, pRB immunoreactivity was high in proliferative areas and low or absent in non-proliferating areas. Our findings and the recent demonstration of significant pRB nuclear staining in cells of normal adult intestinal crypts with absent nuclear staining in the epithelial cells of the vili (Xu et al., 1991) , as well as in germinal centres of reactive lymph nodes (Martinez et al., 1993) , support the contention that pRB expression is cell cycle associated.
RBI protein immunoreactivity was found in-all primary gastric carcinomas analysed, and in the two lymph node metastases. In our study a semiquantitative scoring system p68RS2.0 kb 1.85- and 36 respectively), allelic imbalance (Al). In patients 16 and 36 (C and F) a total klss of one allele on tumour DNA was detected.
All filters have been hybridised to the VNTR probe p68RS2.0, and rehybridised with 3'BCR probe for DNA loading control. x, number of times of difference measured in tumour compared with normal sample; *, 10-50% stained cells; **, 51-100% stained cells. was used to evaluate pRB immunoreactivity, thus minimising the effects of tumour heterogeneity. In the majonrty of cases we observed staining in more than 50% of neoplastic cells. In all cases, therefore, a variable proportion of non-pRB immunoreactive neoplastic cells was noted. This finding can be due to low levels of pRB escaping detection by immuno- histochemistry (a normal phenomenon during the Go/middle GI phases of the cell cycle: Xu et al., 1991; Martinez et al., 1993 ), or to functional or structural abnormalities of the gene. Both possibilities are indistinguishable at the single-cell level. Owing to the cell cycle-dependent expression of pRB a study of the proliferation status of the tumours was therefore conducted.
In gastric carcinomas of the diffuse type we observed significantly lower amounts of pRB and of PCNA than in intestinal and atypical carcinomas. Since previous reports (Saitoh et al., 1992; David et al., 1994) have shown that carcinomas of the diffuse type are less proliferative than intestinal-type carcinomas, our data suggest, although indirectly, that pRB immunoreactivity associates with cell proliferation in gastric cancer. This hypothesis is further supported by our flow cytometric evaluation of cell proliferation in these cases, showing a consistent trend (albeit not statistically significant) between cell proliferative indexes and pRB immunoreactivity scores (data not shown).
It is important to note, however, that PCNA scores probably overestimate the number of proliferative cells, since PCNA is detected in a very high percentage of cells. Previous reports (Hall et al., 1990; Rosa et al., 1992) suggest that PCNA immunoreactivity may be detected in cancer cells that have recently left the cycle owing to the long half-life of the antigen or to alteration of mRNA stability induced by growth factors.
It is tempting to speculate that the same or other epigenetic mechanisms affect pRB expression in gastric carcinomas, as a close relation was found between pRB and PCNA immunoreactivities. Alternatively, pRB may be identifying cell populations in earlier phases of the cell cycle than those identified by PCNA. This hypothesis would explain the cases in which higher immunoreactive scores were observed for pRB than for PCNA.
Western blot analysis revealed normal patterns in the 12 primary gastric carcinomas studied, thus excluding gross changes in pRB. The absence of phosphorylated forms in 'normal' mucosas is a previously well-documented phenomenon (Xu et al., 1991) and occurs because the proliferative fraction (neck zone of the glands) is rather small when compared with the total number of cells and, therefore, undetectable by the technique used. The same explanation and/or stromal contamination may explain the absence of phosphorylated bands in the tumours.
The few studies published on chromosomal abnormalities in stomach cancer using cytogenetic analysis (Ochi et al., 1986; Ferti-Passantonopoulou et al., 1987; Seruca et al., 1993) report, almost unanimously, that chromosome 13 is one of the most common chromosomes affected in these type of tumours. Studies conducted in order to establish the frequency of allele losses on chromosome 13 in primary gastric cancers, reported by Motomura et al. (1988) and Wada et al. (1988) , revealed loss of heterozygosity in 41% and 11% of informative cases respectively. None of these studies, however, was designed to evaluate directly the allelic loss within the retinoblastoma gene.
In our study RB1 structure was checked by Southern blotting, using two genomic probes, and two cDNA probes in the 41 cases of gastric carcinomas. No obvious RB1 rearrangement or homozygous deletions were detected. Allelic imbalance was found in 29% of informative cases. Total loss of one allele was seen in two of the five cases showing allelic imbalance, thus suggesting that in a minor proportion of cases the RB1 gene may be important for the oncogenesis and/or progression of these tumours. On the other hand, the true nature of the remaining cases showing allelic imbalance is difficult to ascertain. They may be due to the result of clonal variation in RB1 copy number (duplication or loss) and/or stromal contamination.
In one case duplication of both alleles was detected. Monosomy of the chromosome 22 control probe was excluded since the filters were rehybridised with other VNTR probes (for chromosomes 6 and 17) and an equal loading in the normal and tumour lanes was confirmed. This finding is probably the result of an increase in chromosome copy number (tetrasomy) as duplication of both tumour alleles was also seen with a telomeric probe (p9A7) (data not shown).
In three cases (28, 30 and 36) , all showing alterations with probe p68RS2.0, the 5.4 and 7.5 kb pG3.8M/HindIII fragments flank-ing this intronic region showed no change in intensity signal when compared with normal mucosa fragments. These findings are therefore suggestive that alterations were confined to this intronic region, which is keeping with the suggestion that the DNA sequence detected by probe p68RS2.0 might contain hotspots for structural aberrations (T'Ang et al., 1989) . Further studies are, however, required to confirm these findings.
It is noteworthy that no clear correlation was found between molecular alterations and loss of pRB immunoreactivity in our series. Similar findings have been described for other tumours in which RBI allelic loss was not accompanied by loss of immunoreactivity (Ishikawa et al., 1991; Borg et al., 1992) . Loss of pRB immunoreactivity also did not correlate with clinicopathological features such as tumour site, tumour staging, vascular invasion, nodal metastases, etc.
In summuary, our results suggest that RB1 does not play, by itself, a crucial role in the oncogenesis of human gastric carcinomas. This contention is based on the following observations: pRB expression was found in all gastric carcinomas analysed and is associated with the proliferation status of the tumours; pRB protein, as assessed by Western blotting, showed normal patterns (110-116 kDa); loss of heterozygosity is not a frequent event and gross alterations such as homozygous deletions and or rearrangements were undetec- 
